Evidence map›Paper›PMID 30013173›Full record

ArticleScientific reports2018

Structural cortical network reorganization associated with early conversion to multiple sclerosis.

C Tur, A Eshaghi, D R Altmann, T M Jenkins, F Prados, F Grussu, T Charalambous, A Schmidt, S Ourselin, J D Clayden and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Advances in brain imaging in multiple sclerosis.Therapeutic advances in neurological disorders · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 3 countries.

C TurQueen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College of London (UCL), London, WC1B 5EH, UK. c.tur@ucl.ac.uk.ORCID 0000-0003-1849-3184
A EshaghiQueen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College of London (UCL), London, WC1B 5EH, UK.
D R AltmannQueen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College of London (UCL), London, WC1B 5EH, UK.
T M JenkinsQueen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College of London (UCL), London, WC1B 5EH, UK.
F PradosQueen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College of London (UCL), London, WC1B 5EH, UK.ORCID 0000-0002-7872-0142
F GrussuQueen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College of London (UCL), London, WC1B 5EH, UK.
T CharalambousQueen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College of London (UCL), London, WC1B 5EH, UK.
A SchmidtDepartment of Psychiatry (UPK), University of Basel, Basel, Switzerland.
S OurselinTranslational Imaging Group, Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, UCL, London, WC1E 7JE, UK.
J D ClaydenUCL Great Ormond Street Institute of Child Health, UCL, London, WC1N 1EH, UK.
C A M G Wheeler-KingshottQueen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College of London (UCL), London, WC1B 5EH, UK.
A J ThompsonQueen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College of London (UCL), London, WC1B 5EH, UK.
O CiccarelliQueen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College of London (UCL), London, WC1B 5EH, UK.
A T ToosyQueen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College of London (UCL), London, WC1B 5EH, UK.
National Hospital for Neurology and Neurosurgery · GBNational Institute for Health Research · GBGreat Ormond Street Hospital · GBMRC Prion Unit · GBUniversity College London · GBUniversity of Basel · CHUniversity of London · GBUniversity of Pavia · IT

Funding

Medical Research Council MR/J01107X/1
6 · The paper itself

Abstract

Brain structural covariance networks (SCNs) based on pairwise statistical associations of cortical thickness data across brain areas reflect underlying physical and functional connections between them. SCNs capture the complexity of human brain cortex structure and are disrupted in neurodegenerative conditions. However, the longitudinal assessment of SCN dynamics has not yet been explored, despite its potential to unveil mechanisms underlying neurodegeneration. Here, we evaluated the changes of SCNs over 12 months in patients with a first inflammatory-demyelinating attack of the Central Nervous System and assessed their clinical relevance by comparing SCN dynamics of patients with and without conversion to multiple sclerosis (MS) over one year. All subjects underwent clinical and brain MRI assessments over one year. Brain cortical thicknesses for each subject and time point were used to obtain group-level between-area correlation matrices from which nodal connectivity metrics were obtained. Robust bootstrap-based statistical approaches (allowing sampling with replacement) assessed the significance of longitudinal changes. Patients who converted to MS exhibited significantly greater network connectivity at baseline than non-converters (p = 0.02) and a subsequent connectivity loss over time (p = 0.001-0.02), not observed in non-converters' network. These findings suggest SCN analysis is sensitive to brain tissue changes in early MS, reflecting clinically relevant aspects of the condition. However, this is preliminary work, indicated by the low sample sizes, and its results and conclusions should be treated with caution and confirmed with larger cohorts.

Indexed as

ConnectomeAdultAtrophyDisease ProgressionFemaleFollow-Up StudiesGray MatterHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingMaleMultiple SclerosisNerve Net

Identifiers

PMID30013173
PMCPMC6048099
OpenAlexW2843786466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.